These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6718959)

  • 21. [Beneficial action of Tiapride on the choreic or nonchoreic abnormal movements of the aged].
    Graux P; Durocher AM; Frigard B
    Lille Med; 1978 Apr; 23(4):271-3. PubMed ID: 651559
    [No Abstract]   [Full Text] [Related]  

  • 22. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea.
    Fenney A; Jog MS; Duval C
    Clin Neurol Neurosurg; 2008 Feb; 110(2):160-7. PubMed ID: 18063471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [How to clinically approach involuntary movements].
    Shibasaki H
    Rinsho Shinkeigaku; 2003 Nov; 43(11):752-5. PubMed ID: 15152456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study.
    Jankovic J
    Ann Neurol; 1982 Jan; 11(1):41-7. PubMed ID: 6460467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Present-day treatment of dyskinesias (author's transl)].
    Fonsegrive J
    Sem Hop; 1979 Jan 8-15; 55(1-2):88-9. PubMed ID: 34220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hyperkinetic syndromes. Therapeutic trials].
    Severini P; Pompili A; Pierini G
    Riv Neurol; 1978; 48(2):242-8. PubMed ID: 276041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic use of tiapride in movement disorders].
    Mathé JF; Cler JM; Venisse JL
    Sem Hop; 1978 May; 54(13-16):517-20. PubMed ID: 211595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A new therapeutical approach in neurology (author's transl)].
    Divisia A; Girard-Madoux M
    Sem Hop; 1978 Nov 18-25; 54(41-42):1265-8. PubMed ID: 216105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dyskinetic syndromes in psychiatric patients (author's transl)].
    Lutrand JC; Ducamin JP
    Sem Hop; 1978 Dec 18-25; 54(45-46):1465-8. PubMed ID: 34882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Involuntary movements as a complication of treatment of extrapyramidal disorders with L-dopa].
    Friedman A; Markowa E
    Neurol Neurochir Pol; 1981; 15(4):437-40. PubMed ID: 6460200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)].
    Tissot R; Gaillard JM; Guggisberg M; Gauthier G; de Ajuriaguerra J
    Presse Med (1893); 1969 Apr; 77(17):619-22. PubMed ID: 5785081
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of Parkinson's disease: levodopa as the first choice.
    Katzenschlager R; Lees AJ
    J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Abnormal movements and shaking in geriatrics (author's transl)].
    Chabaud R; Guenoun M; Taddei JP; Guillou J
    Sem Hop; 1979 Mar 8-15; 55(9-10):465-9. PubMed ID: 38513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [L-DOPA-induced dyskinesia].
    Derkinderen P; Vidailhet M
    Rev Neurol (Paris); 2002; 158(122):92-101. PubMed ID: 12690319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral subthalamic nucleus lesion reverses L-dopa-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats.
    Marin C; Jiménez A; Tolosa E; Bonastre M; Bové J
    Synapse; 2004 Feb; 51(2):140-50. PubMed ID: 14618681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Action of trazodone on pyramidal hypertension. Clinical study].
    Montanini R; Zibetti A
    Riv Neurol; 1984; 54(6):367-73. PubMed ID: 6396826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease.
    Schumacher G; Platz KP; Mueller AR; Neuhaus R; Steinmüller T; Bechstein WO; Becker M; Luck W; Schuelke M; Neuhaus P
    Clin Transplant; 1997 Jun; 11(3):217-24. PubMed ID: 9193846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sepiapterin reductase deficiency: a congenital dopa-responsive motor and cognitive disorder.
    Neville BG; Parascandalo R; Farrugia R; Felice A
    Brain; 2005 Oct; 128(Pt 10):2291-6. PubMed ID: 16049044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tandospirone citrate, a selective 5-HT1A agonist, alleviates L-DOPA-induced dyskinesia in patients with Parkinson's disease].
    Kannari K; Kurahashi K; Tomiyama M; Maeda T; Arai A; Baba M; Suda T; Matsunaga M
    No To Shinkei; 2002 Feb; 54(2):133-7. PubMed ID: 11889759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined use of trazodone and phenelzine in depression: case report.
    Zetin M
    J Clin Psychiatry; 1984 Apr; 45(4):182-3. PubMed ID: 6715295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.